NDA Regulatory Services
NDA is a leading global regulatory affairs and drug development consultancy with over 25 years of experience in helping clients gain approval for their medicines.
With a portfolio of over 1600 clients worldwide, we specialize in helping pharmaceutical and biotech companies navigate the complex and ever-changing regulatory landscape in Europe, the US, and the UK, with a focus on oncology, advanced therapies, and rare diseases.
Our exceptional track record speaks for itself, as we have played a critical role in the approval of a quarter of all new medicines in the US and EU in the last 3 years.
As a leading consultancy in the industry, we provide unmatched regulatory expertise and partner with our clients to optimize the development of complex and innovative treatments that meet the demanding standards of regulatory agencies.